Felpreva®是一种新的含有替戈拉纳、依莫地肽和吡喹酮的配方,单次应用于人工感染耳螨的猫(Otodectes cynotis)的疗效

Katrin Blazejak , Alta Viljoen , Reinier Zwiegers , Roland Klopper , Hannah Ringeisen , Gabriele Petry , David R. Young , Douglas Shane , Jennifer Spruill , Ronald K. Tessman , Terry Settje , Tanja N. Knoppe , Norbert Mencke
{"title":"Felpreva®是一种新的含有替戈拉纳、依莫地肽和吡喹酮的配方,单次应用于人工感染耳螨的猫(Otodectes cynotis)的疗效","authors":"Katrin Blazejak ,&nbsp;Alta Viljoen ,&nbsp;Reinier Zwiegers ,&nbsp;Roland Klopper ,&nbsp;Hannah Ringeisen ,&nbsp;Gabriele Petry ,&nbsp;David R. Young ,&nbsp;Douglas Shane ,&nbsp;Jennifer Spruill ,&nbsp;Ronald K. Tessman ,&nbsp;Terry Settje ,&nbsp;Tanja N. Knoppe ,&nbsp;Norbert Mencke","doi":"10.1016/j.crpvbd.2023.100131","DOIUrl":null,"url":null,"abstract":"<div><p>The efficacy of Felpreva® (Vetoquinol), a new spot-on application containing the novel acaricide and insecticide tigolaner in combination with emodepside and praziquantel, was evaluated in cats artificially infested with ear mites (<em>Otodectes cynotis</em>). A total of three pivotal dose confirmation studies were conducted, two of them designed as non-interference studies. Cats were artificially infested with <em>O. cynotis</em> mites and randomly allocated into groups of 8 cats based on pre-treatment mite counts. Cats were treated once on Day 0, either with Felpreva® (14.5 ​mg/kg tigolaner, 3 ​mg/kg emodepside and 12 ​mg/kg praziquantel) or with placebo. Studies with a non-interference design included two additional groups of cats, treated with Profender® spot-on solution (Vetoquinol) (3 ​mg/kg emodepside and 12 ​mg/kg praziquantel) and tigolaner as a mono product (14.5 ​mg/kg tigolaner). Efficacy was evaluated on Day 28/Day 30 based on total live mite counts after ear flushing. Efficacy was claimed when: (i) at least six control cats per group were adequately infested with mites; (ii) calculated efficacy was ≥ 90% based on geometric mean mite counts; and (iii) the difference in mite counts between Felpreva®-treated cats and control cats was statistically significant (<em>P</em> ​≤ ​0.05). In two of the three studies, Felpreva®-treated cats were mite-free (100% efficacy) on Day 28/Day 30 and almost full efficacy (99.6%) was seen in the third study. The difference in mite counts between Felpreva®-treated cats and control cats was significant (<em>P</em> ​&lt; ​0.0001) in all three studies. All control cats were adequately infested in all three studies. The efficacy of Felpreva® against ear mite (<em>Otodectes cynotis</em>) infection in cats was confirmed.</p></div>","PeriodicalId":94311,"journal":{"name":"Current research in parasitology & vector-borne diseases","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Efficacy of Felpreva®, a new spot-on formulation containing tigolaner, emodepside and praziquantel, applied as a single application to cats artificially infested with ear mites (Otodectes cynotis)\",\"authors\":\"Katrin Blazejak ,&nbsp;Alta Viljoen ,&nbsp;Reinier Zwiegers ,&nbsp;Roland Klopper ,&nbsp;Hannah Ringeisen ,&nbsp;Gabriele Petry ,&nbsp;David R. Young ,&nbsp;Douglas Shane ,&nbsp;Jennifer Spruill ,&nbsp;Ronald K. Tessman ,&nbsp;Terry Settje ,&nbsp;Tanja N. Knoppe ,&nbsp;Norbert Mencke\",\"doi\":\"10.1016/j.crpvbd.2023.100131\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The efficacy of Felpreva® (Vetoquinol), a new spot-on application containing the novel acaricide and insecticide tigolaner in combination with emodepside and praziquantel, was evaluated in cats artificially infested with ear mites (<em>Otodectes cynotis</em>). A total of three pivotal dose confirmation studies were conducted, two of them designed as non-interference studies. Cats were artificially infested with <em>O. cynotis</em> mites and randomly allocated into groups of 8 cats based on pre-treatment mite counts. Cats were treated once on Day 0, either with Felpreva® (14.5 ​mg/kg tigolaner, 3 ​mg/kg emodepside and 12 ​mg/kg praziquantel) or with placebo. Studies with a non-interference design included two additional groups of cats, treated with Profender® spot-on solution (Vetoquinol) (3 ​mg/kg emodepside and 12 ​mg/kg praziquantel) and tigolaner as a mono product (14.5 ​mg/kg tigolaner). Efficacy was evaluated on Day 28/Day 30 based on total live mite counts after ear flushing. Efficacy was claimed when: (i) at least six control cats per group were adequately infested with mites; (ii) calculated efficacy was ≥ 90% based on geometric mean mite counts; and (iii) the difference in mite counts between Felpreva®-treated cats and control cats was statistically significant (<em>P</em> ​≤ ​0.05). In two of the three studies, Felpreva®-treated cats were mite-free (100% efficacy) on Day 28/Day 30 and almost full efficacy (99.6%) was seen in the third study. The difference in mite counts between Felpreva®-treated cats and control cats was significant (<em>P</em> ​&lt; ​0.0001) in all three studies. All control cats were adequately infested in all three studies. The efficacy of Felpreva® against ear mite (<em>Otodectes cynotis</em>) infection in cats was confirmed.</p></div>\",\"PeriodicalId\":94311,\"journal\":{\"name\":\"Current research in parasitology & vector-borne diseases\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current research in parasitology & vector-borne diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667114X23000195\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PARASITOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current research in parasitology & vector-borne diseases","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667114X23000195","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PARASITOLOGY","Score":null,"Total":0}
引用次数: 2

摘要

Felpreva®(Vetoquinol)是一种新的应用点,含有新型杀螨剂和杀虫剂替戈拉纳,与依莫地肽和吡喹酮联合使用,对人工感染耳螨(Otodectes cynotis)的猫的疗效进行了评估。共进行了三项关键剂量确认研究,其中两项被设计为不干扰研究。猫被人工感染O.cynotis螨,并根据预处理螨数随机分为8只猫。猫在第0天接受一次Felpreva®(14.5​mg/kg替戈拉纳,3​毫克/千克大鼠苷和12​mg/kg吡喹酮)或与安慰剂。非干扰设计的研究包括另外两组猫,用Profender®现场溶液(Vetoquinol)治疗(3​毫克/千克大鼠苷和12​mg/kg吡喹酮)和替戈拉纳作为单一产品(14.5​mg/kg替戈拉纳)。在第28天/30天,基于洗耳后的总活螨计数来评估疗效。当:(i)每组至少有六只对照猫被螨虫充分感染时,就声称有疗效;(ii)基于几何平均螨数计算的疗效≥90%;和(iii)Felpreva®治疗猫和对照猫的螨数差异具有统计学意义(P​≤​0.05)。在三项研究中的两项研究中,Felpreva®治疗的猫在第28天/30天无螨(100%有效),第三项研究几乎完全有效(99.6%)。Felpreva®治疗猫和对照猫的螨数差异显著(P​<;​0.0001)。在所有三项研究中,所有对照猫都受到了充分的感染。Felpreva®对猫耳螨(Otodectes cynotis)感染的疗效已得到证实。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Efficacy of Felpreva®, a new spot-on formulation containing tigolaner, emodepside and praziquantel, applied as a single application to cats artificially infested with ear mites (Otodectes cynotis)

The efficacy of Felpreva® (Vetoquinol), a new spot-on application containing the novel acaricide and insecticide tigolaner in combination with emodepside and praziquantel, was evaluated in cats artificially infested with ear mites (Otodectes cynotis). A total of three pivotal dose confirmation studies were conducted, two of them designed as non-interference studies. Cats were artificially infested with O. cynotis mites and randomly allocated into groups of 8 cats based on pre-treatment mite counts. Cats were treated once on Day 0, either with Felpreva® (14.5 ​mg/kg tigolaner, 3 ​mg/kg emodepside and 12 ​mg/kg praziquantel) or with placebo. Studies with a non-interference design included two additional groups of cats, treated with Profender® spot-on solution (Vetoquinol) (3 ​mg/kg emodepside and 12 ​mg/kg praziquantel) and tigolaner as a mono product (14.5 ​mg/kg tigolaner). Efficacy was evaluated on Day 28/Day 30 based on total live mite counts after ear flushing. Efficacy was claimed when: (i) at least six control cats per group were adequately infested with mites; (ii) calculated efficacy was ≥ 90% based on geometric mean mite counts; and (iii) the difference in mite counts between Felpreva®-treated cats and control cats was statistically significant (P ​≤ ​0.05). In two of the three studies, Felpreva®-treated cats were mite-free (100% efficacy) on Day 28/Day 30 and almost full efficacy (99.6%) was seen in the third study. The difference in mite counts between Felpreva®-treated cats and control cats was significant (P ​< ​0.0001) in all three studies. All control cats were adequately infested in all three studies. The efficacy of Felpreva® against ear mite (Otodectes cynotis) infection in cats was confirmed.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.60
自引率
0.00%
发文量
0
期刊最新文献
Editorial Board Table of Contents An abortion storm in a goat farm in the Northeast Region of Brazil was caused by the atypical Toxoplasma gondii genotype #13 Helminth fauna of the black goby Gobius niger L. (Gobiiformes: Gobiidae) from the Finnish Archipelago, Baltic Sea: Molecular and morphological data A case of abnormal swimming patterns in juvenile Oblada melanura naturally infected with Philometra obladae (Nematoda: Philometridae) in the Tyrrhenian Sea off Sicily, Italy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1